本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Protagonist Therapeutics Inc

147.35
-0.8300-0.56%
成交量:7.08萬
成交額:1,052.75萬
市值:95.35億
市盈率:143.06
高:150.16
開:149.92
低:147.09
收:148.18
52周最高:160.81
52周最低:57.90
股本:6,470.83萬
流通股本:6,316.60萬
量比:0.72
換手率:0.11%
股息:- -
股息率:- -
每股收益(TTM):1.03
每股收益(LYR):-2.0500
淨資產收益率:10.98%
總資產收益率:4.55%
市淨率:11.33
市盈率(LYR):-71.88

資料載入中...

2020/05/07

季度報告

Quarterly report [Sections 13 or 15(d)]
2020/03/18

重要事件披露

Current report, items 4.01 and 9.01
2020/03/10

員工持股計劃

Securities to be offered to employees in employee benefit plans
2020/03/10

年度報告

Annual report [Section 13 and 15(d), not S-K Item 405]
2020/03/10

重要事件披露

Current report, items 2.02 and 9.01
2020/02/24

重要事件披露

Current report, items 5.02 and 9.01
2020/02/14

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/14

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/14

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/14

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/14

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/07

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/07

超過5%披露

Statement of acquisition of beneficial ownership by individuals
2019/12/16

超過5%披露

Statement of acquisition of beneficial ownership by individuals
2019/12/03

重要事件披露

Current report, items 8.01 and 9.01
2019/11/27

重要事件披露

Current report, items 1.01 and 9.01
2019/11/20

SEC問詢函

[Cover]Correspondence
2019/11/06

季度報告

Quarterly report [Sections 13 or 15(d)]
2019/11/06

重要事件披露

Current report, items 2.02 and 9.01
2019/10/31

重要事件披露

Current report, items 1.01, 2.03, and 3.03